|
TAX1BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.483600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.051400E-01 |
| Normal-vs-Stage2 |
6.979600E-01 |
| Normal-vs-Stage3 |
8.113600E-01 |
| Normal-vs-Stage4 |
1.311810E-01 |
| Stage1-vs-Stage2 |
8.246800E-01 |
| Stage1-vs-Stage3 |
2.975600E-01 |
| Stage1-vs-Stage4 |
3.848100E-02 |
| Stage2-vs-Stage3 |
6.165000E-01 |
| Stage2-vs-Stage4 |
2.526000E-01 |
| Stage3-vs-Stage4 |
4.033600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.300200E-01 |
| Normal-vs-AfricanAmerican |
3.013800E-01 |
| Normal-vs-Asian |
5.809800E-01 |
| Caucasian-vs-AfricanAmerican |
6.550200E-01 |
| Caucasian-vs-Asian |
6.757800E-01 |
| AfricanAmerican-vs-Asian |
8.175400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.777400E-01 |
| Normal-vs-Female |
4.040100E-02 |
| Male-vs-Female |
8.249800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.571800E-01 |
| Normal-vs-Extreme_Weight |
4.740200E-01 |
| Normal-vs-Obese |
2.828200E-01 |
| Normal-vs-Extreme_Obese |
7.221600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.032200E-01 |
| Normal_Weight-vs-Obese |
4.792400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.386200E-01 |
| Extreme_Weight-vs-Obese |
8.122800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.464600E-01 |
| Obese-vs-Extreme_Obese |
9.609600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.558000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.332000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.893200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.744600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.589400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.830000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.370000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.640100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.458400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.495000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.369560E-02 |
| Normal-VS-Type2 PRCC |
7.957000E-01 |
| Normal-VS-KIRP CIMP |
7.463400E-01 |
| Normal-VS-Unclassified PRCC |
8.158000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.144200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.325990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.630000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.660800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.202400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.834000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.659800E-01 |
| Normal-vs-N1 |
8.375200E-01 |
| Normal-vs-N2 |
1.798640E-01 |
| N0-vs-N1 |
6.333400E-01 |
| N0-vs-N2 |
7.308800E-01 |
| N1-vs-N2 |
4.764000E-01 |
|
|
